Solid Biosciences Inc.(SLDB)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Solid Biosciences Inc. (SLDB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SLDB is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Solid Biosciences Inc. reports net income of $-54.8M, free cash flow of $-52.7M. Top institutional holders of SLDB by reported 13-F value include RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS, Bain Capital Life Sciences Investors, based on the most recent SEC filings. SLDB trades on the Nasdaq exchange and files with the SEC under CIK 1707502. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SLDB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Solid Biosciences Inc. directly from SEC EDGAR.

Net Income

$-54.8M

Free Cash Flow

$-52.7M

SLDB key financials by period

Solid Biosciences Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202210-K$8.1M
FY 202110-K$13.6M

Institutions holding SLDB

Institutional investors reporting a position in Solid Biosciences Inc. on SEC Form 13F.
InstitutionSharesValueReported
RA CAPITAL MANAGEMENT, L.P.12,036,126$120.2M2026-06-30
PERCEPTIVE ADVISORS11,906,646$118.9M2026-06-30
Bain Capital Life Sciences Investors9,808,819$98.0M2026-06-30
Siren, L.L.C.7,690,405$76.8M2026-06-30
BlackRock6,934,248$69.3M2026-06-30
FMR6,875,957$68.7M2026-06-30
ARMISTICE CAPITAL4,278,000$42.7M2026-06-30
STATE STREET4,175,365$41.7M2026-06-30
Jupiter Topco4,043,605$40.4M2026-06-30
VANGUARD CAPITAL MANAGEMENT4,009,922$40.1M2026-06-30
SLDB

Solid Biosciences Inc.

SLDB
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-54.80M

EPS (Diluted)

Q2 2026
EDGAR

$-0.38

ROIC

Q2 2026
EDGAR

-61.4%

Free Cash Flow

Q2 2026
EDGAR

$-52.74M

Top Institutional Holders

as of Q2 2026
$1.15B total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…